Aerovate Therapeutics, Inc. - COM (AVTE)

Historical Portfolio Holders from Q2 2021 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
27.2M
Holdings value Q2 2024
$45.1M
Value change Q2 2024
-$189M
Grand Portfolio weight change Q2 2024
0%
Number of holders
79
Number of buys Q2 2024
58
Number of sells Q2 2024
-43
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 11K $23K -$352K $2.09 1
2024 Q2 27.2M $45.1M -$189M $1.66 83
2024 Q1 28.4M $841M +$12.9M $29.57 79
2023 Q4 24.4M $552M -$448K $22.63 62
2023 Q3 28.5M $386M -$1.3M $13.57 58
2023 Q2 28.5M $488M +$39.1M $17.15 60
2023 Q1 26M $524M -$46.6M $20.17 65
2022 Q4 27.4M $803M +$17.8M $29.30 68
2022 Q3 27M $447M +$20.2M $16.58 53
2022 Q2 25.8M $403M -$2.77M $15.63 47
2022 Q1 25.9M $475M +$8.65M $18.33 44
2021 Q4 25.6M $301M -$15.3M $11.79 46
2021 Q3 21.7M $453M +$35.1M $20.98 41
2021 Q2 20M $454M +$454M $22.83 17